|
US2940972A
(en)
|
1957-06-27 |
1960-06-14 |
Thomae Gmbh Dr K |
Tri-and tetra-substituted pteridine derivatives
|
|
US2963481A
(en)
|
1959-11-27 |
1960-12-06 |
Smith Kline French Lab |
6-pteridinecarboxylic acid esters
|
|
US3712892A
(en)
|
1969-08-02 |
1973-01-23 |
Sumitomo Chemical Co |
Quinazolinone derivatives
|
|
JPH05170744A
(ja)
*
|
1991-12-25 |
1993-07-09 |
Toray Dow Corning Silicone Co Ltd |
含窒素芳香族複素環式化合物のアルキル化方法
|
|
IL112235A
(en)
|
1994-01-03 |
2000-06-29 |
Acea Pharm Inc |
1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them
|
|
SI1028950T1
(en)
|
1997-10-28 |
2003-08-31 |
Warner-Lambert Company Llc |
7-substituted quinazolin-2,4-diones useful as antibacterial agents
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
JP2004521892A
(ja)
|
2000-12-20 |
2004-07-22 |
メルク エンド カムパニー インコーポレーテッド |
（ハロ−ベンゾカルボニル）複素環縮合フェニル系ｐ３８キナーゼ阻害剤
|
|
JP2003005355A
(ja)
|
2001-06-20 |
2003-01-08 |
Fuji Photo Film Co Ltd |
電子線又はｘ線用ネガ型レジスト組成物
|
|
ES2440217T3
(es)
|
2002-10-04 |
2014-01-28 |
Prana Biotechnology Limited |
Compuestos neurológicamente activos
|
|
GB0229281D0
(en)
*
|
2002-12-16 |
2003-01-22 |
Novartis Ag |
Organic compounds
|
|
WO2005007099A2
(en)
|
2003-07-10 |
2005-01-27 |
Imclone Systems Incorporated |
Pkb inhibitors as anti-tumor agents
|
|
PT1673092E
(pt)
|
2003-10-17 |
2007-11-23 |
4 Aza Ip Nv |
''derivados de pteridina substituídos com heterociclos e sua utilização em terapia''
|
|
CA2543710A1
(en)
|
2003-11-03 |
2005-05-12 |
Warner-Lambert Company Llc |
Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
|
|
BRPI0507629A
(pt)
|
2004-02-13 |
2007-07-03 |
Banyu Pharma Co Ltd |
composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
|
|
WO2005087742A1
(en)
*
|
2004-03-08 |
2005-09-22 |
Exelixis, Inc. |
Metabolic kinase modulators and methods of use as pesticides
|
|
DK1737831T3
(da)
|
2004-04-02 |
2013-08-19 |
Prana Biotechnology Ltd |
Neurologisk aktive forbindelser
|
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
|
MX2007010401A
(es)
*
|
2005-02-25 |
2008-02-19 |
Kudos Pharm Ltd |
Derivados de 2,4-diamino-piridopirimidina y su uso como inhbidores de mtor.
|
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
KR100659088B1
(ko)
|
2005-07-15 |
2006-12-21 |
삼성에스디아이 주식회사 |
디플루오로피리딘계 화합물 및 이를 이용한 유기 발광 소자
|
|
WO2007038331A2
(en)
|
2005-09-23 |
2007-04-05 |
Smithkline Beecham Corporation |
Novel chemical compounds
|
|
EP1996191A4
(en)
|
2006-03-02 |
2010-05-19 |
Glaxosmithkline Llc |
THIAZOLONE AS A PI3 KINASE INHIBITOR
|
|
US7855194B2
(en)
*
|
2006-03-27 |
2010-12-21 |
Hoffmann-La Roche Inc. |
Pyrimidine, quinazoline, pteridine and triazine derivatives
|
|
US20090318456A1
(en)
|
2006-07-06 |
2009-12-24 |
Gilead Sciences, Inc. |
Substituted pteridines for the treatment and prevention of viral infections
|
|
US7635683B2
(en)
|
2006-08-04 |
2009-12-22 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl tripeptide hepatitis C virus inhibitors
|
|
JP5227321B2
(ja)
|
2006-08-23 |
2013-07-03 |
クドス ファーマシューティカルズ リミテッド |
Ｍｔｏｒ阻害剤としての２−メチルモルホリンピリド−、ピラゾ−及びピリミド−ピリミジン誘導体
|
|
EP2142509B1
(en)
|
2007-04-18 |
2013-12-04 |
Amgen, Inc |
Quinolones and azaquinolones that inhibit prolyl hydroxylase
|
|
US20090099195A1
(en)
*
|
2007-05-08 |
2009-04-16 |
Astrazeneca Ab |
Therapeutic Compounds 570
|
|
BRPI0818426A2
(pt)
|
2007-10-15 |
2017-06-13 |
Astrazeneca Ab |
produto de combinação, uso de um produto de combinação, e, método para tratar câncer
|
|
US20110098267A1
(en)
|
2008-02-07 |
2011-04-28 |
Synta Pharmaceuticals Corporation |
Topical formulations for the treatment of psoriasis
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
WO2010033906A2
(en)
|
2008-09-19 |
2010-03-25 |
President And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
|
ES2617873T3
(es)
|
2008-10-10 |
2017-06-20 |
Vm Discovery, Inc. |
Composiciones y métodos para tratar trastornos de alcoholismo, dolor y otras enfermedades
|
|
JP2012520887A
(ja)
|
2009-03-18 |
2012-09-10 |
シェーリング コーポレイション |
ジアシルグリセロールアシルトランスフェラーゼの阻害剤としての二環式化合物
|
|
US8691187B2
(en)
|
2009-03-23 |
2014-04-08 |
Eli Lilly And Company |
Imaging agents for detecting neurological disorders
|
|
CN102574847A
(zh)
|
2009-07-30 |
2012-07-11 |
Irm责任有限公司 |
作为syk激酶抑制剂的化合物和组合物
|
|
WO2011014039A1
(en)
|
2009-07-31 |
2011-02-03 |
Rohm And Haas Electronic Materials Korea Ltd. |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
|
US20110124597A1
(en)
|
2009-09-25 |
2011-05-26 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
|
JP5993742B2
(ja)
|
2009-10-29 |
2016-09-14 |
ジェノスコ |
キナーゼ阻害剤
|
|
EP2547664B1
(de)
*
|
2010-03-16 |
2016-05-04 |
Merck Patent GmbH |
Morpholinylchinazoline
|
|
WO2011156889A1
(en)
|
2010-06-14 |
2011-12-22 |
Trt Pharma Inc. |
Novel modulators of nrf2 and uses thereof
|
|
US10260097B2
(en)
*
|
2011-06-02 |
2019-04-16 |
Almac Diagnostics Limited |
Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
|
|
CN102887895B
(zh)
|
2011-07-22 |
2016-08-24 |
山东轩竹医药科技有限公司 |
吡啶并嘧啶类mTOR抑制剂
|
|
KR101497124B1
(ko)
|
2011-11-28 |
2015-03-06 |
덕산네오룩스 주식회사 |
유기전기소자용 화합물, 이를 포함하는 유기전기소자 및 그 전자 장치
|
|
EA039373B1
(ru)
|
2012-02-08 |
2022-01-19 |
Янссен Сайенсиз Айрлэнд Юси |
Производные пиперидино-пиримидина для лечения вирусных инфекций
|
|
CN103374021B
(zh)
|
2012-04-21 |
2015-10-28 |
通化济达医药有限公司 |
含有锌结合基的吡啶并嘧啶类HDAC和mTOR抑制剂
|
|
WO2014146249A1
(en)
*
|
2013-03-19 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
|
|
EP3027616B1
(en)
|
2013-07-30 |
2018-01-10 |
Boehringer Ingelheim International GmbH |
Azaindole compounds as modulators of rorc
|
|
US9815797B2
(en)
|
2013-12-09 |
2017-11-14 |
Ucb Biopharma Sprl |
Fused bicyclic heteroaromatic derivatives as modulators of TNF activity
|
|
KR20150080966A
(ko)
|
2014-01-02 |
2015-07-13 |
최돈수 |
유기 전기 발광 소자용 발광 재료, 이를 이용한 유기 전기 발광 소자 및 유기 전기 발광 소자용 재료
|
|
KR20160060572A
(ko)
|
2014-11-19 |
2016-05-30 |
주식회사 엠비케이 |
유기 발광 화합물, 잉크 조성물, 유기 발광 소자 및 전자 기기
|
|
PE20180316A1
(es)
|
2015-04-15 |
2018-02-09 |
Hoffmann La Roche |
Compuestos piridopirimidinona y su uso como moduladores del receptor de nmda
|
|
US10403826B2
(en)
|
2015-05-07 |
2019-09-03 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
EP3335254B1
(de)
|
2015-08-11 |
2020-04-08 |
Merck Patent GmbH |
Materialien für organische elektrolumineszenzvorrichtungen
|
|
WO2017031427A1
(en)
|
2015-08-19 |
2017-02-23 |
3-V Biosciences, Inc. |
COMPOUNDS AND METHODS FOR INHIBITING mTOR
|
|
KR102606277B1
(ko)
|
2016-04-06 |
2023-11-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
|
US10573692B2
(en)
|
2016-04-06 |
2020-02-25 |
Samsung Display Co., Ltd. |
Organic light-emitting device having a sealing thin film encapsulation portion
|
|
IL307931A
(en)
|
2016-04-15 |
2023-12-01 |
Epizyme Inc |
Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors
|
|
CA3039124A1
(en)
|
2016-10-04 |
2018-04-12 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as fxr agonists and methods of use thereof
|
|
WO2018066812A1
(en)
|
2016-10-05 |
2018-04-12 |
Rohm And Haas Electronic Materials Korea Ltd. |
Organic electroluminescent compound and organic electroluminescent device comprising the same
|
|
CN109790183A
(zh)
|
2016-12-13 |
2019-05-21 |
广州华睿光电材料有限公司 |
金属有机配合物及其应用、混合物、有机电子器件
|
|
GB201700814D0
(en)
*
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
TW201843143A
(zh)
|
2017-03-13 |
2018-12-16 |
德商麥克專利有限公司 |
含有芳基胺結構之化合物
|
|
WO2018169352A1
(en)
|
2017-03-16 |
2018-09-20 |
Rohm And Haas Electronic Materials Korea Ltd. |
Organic electroluminescent device
|
|
KR102335935B1
(ko)
|
2017-03-22 |
2021-12-06 |
덕산네오룩스 주식회사 |
유기전기소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
|
AU2018243749A1
(en)
|
2017-03-31 |
2019-11-21 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors
|
|
KR102389204B1
(ko)
|
2017-04-18 |
2022-04-21 |
덕산네오룩스 주식회사 |
유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
|
WO2018195450A1
(en)
|
2017-04-21 |
2018-10-25 |
Epizyme, Inc. |
Combination therapies with ehmt2 inhibitors
|
|
WO2018204765A1
(en)
|
2017-05-05 |
2018-11-08 |
Pairnomix, Llc |
Methods of treating epilepsy and kcnq2 related conditions
|
|
WO2018227228A1
(en)
|
2017-06-13 |
2018-12-20 |
Commonwealth Scientific And Industrial Research Organisation |
Antiviral drugs
|
|
US20200275661A1
(en)
|
2017-09-26 |
2020-09-03 |
Nippon Soda Co., Ltd. |
Quinoline compound, and agricultural and horticultural fungicide
|
|
AU2018353150B2
(en)
|
2017-10-18 |
2024-06-06 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors in treating or preventing blood disorders
|
|
US20210213014A1
(en)
|
2017-10-18 |
2021-07-15 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors in immunotherapies
|
|
CN108484680B
(zh)
|
2018-01-31 |
2020-12-11 |
马鞍山南京大学高新技术研究院 |
一类双硫代芳环/芳杂环磷酸化合物作为辅助配体的铱配合物
|
|
MX2020010836A
(es)
|
2018-05-04 |
2021-01-08 |
Amgen Inc |
Inhibidores de kras g12c y métodos para su uso.
|
|
US12453279B2
(en)
|
2018-08-22 |
2025-10-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
CN109265457A
(zh)
|
2018-11-01 |
2019-01-25 |
中国药科大学 |
一种利用氧化芳构化构建吡啶并嘧啶二酮骨架的新方法
|
|
EP3966208A4
(en)
|
2019-05-10 |
2024-01-03 |
Antidote IP Holdings, LLC |
COMPOUNDS AND METHODS FOR TREATING CANCER
|
|
CN110283171A
(zh)
|
2019-07-17 |
2019-09-27 |
鼎泰(南京)临床医学研究有限公司 |
一类含有吡啶并嘧啶-4-胺类结构的化合物、药物组合物以及其应用
|
|
US11820783B2
(en)
|
2019-09-06 |
2023-11-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
CN116322696A
(zh)
|
2020-05-04 |
2023-06-23 |
安进公司 |
作为髓样细胞上表达的触发受体2激动剂的杂环化合物和使用方法
|
|
KR20230005893A
(ko)
|
2020-05-04 |
2023-01-10 |
다케다 야쿠힌 고교 가부시키가이샤 |
내강 작용 n-(피페리딘-4-일)벤즈아미드 유도체
|
|
BR112022022281A2
(pt)
|
2020-05-04 |
2023-01-03 |
Adama Makhteshim Ltd |
Misturas e composições compreendendo 5-fluoro-4-imino-3-metil- 1-tosil-3,4-dihidropirimidin-2-ona e métodos de uso das mesmas
|
|
TW202208355A
(zh)
|
2020-05-04 |
2022-03-01 |
美商安進公司 |
作為骨髓細胞觸發受體2促效劑之雜環化合物及使用方法
|
|
CN111454265B
(zh)
|
2020-05-07 |
2021-08-24 |
宁波卢米蓝新材料有限公司 |
一种稠杂环化合物及其制备方法和应用
|
|
CN118633022A
(zh)
|
2022-01-11 |
2024-09-10 |
雷杰纳荣制药公司 |
骨髓细胞上表达的触发受体2(trem2)变体以及其在治疗阿尔茨海默病中的用途
|